Induced Emerging Markets:Biosimilar Industry

         The generic drug industry is very developed by its low cost and selling price in India,the India even been as "world drugstore".In general,when the expensive drugs appeared on the western market,the Indian pharmaceutical companies will imitated similar as indian patent law.
         Chinese pharmaceutical companies often desired to do the same as Indians,which will come true during the chinese generic drug market changes.Firstly,the data shows that the world will have as many as 631 patent medicine expires from 2012 to 2017.For many developing countries,this mean that the generic drugs will have more market space.Then,the data shows that China will be the second largest pharmaceutical markets in the 2015.The compound annual growth rate will reach 16.7% from 2012 to 2017 and the chinese pharmaceutical market is the fastest growing in the world market.
         China Merchants Securities,a researcher said that Patent cliff (patent medicine expiring) make a tremendous opportunity for the generic pharmaceutical companies.It will take about 10-15 years to research,develop,approve and product the original drug,the expensive drug of research and development costs will be as high as billions of dollars.By contrast,generic process is simple and the cost is decreased.The domestic generic drug value may be close to 500 billion.

By Ann